Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis

The Biochemical Journal
G SzakácsAndrás Váradi

Abstract

The human multidrug resistance protein (MDR1) (P-glycoprotein), a member of the ATP-binding cassette (ABC) family, causes multidrug resistance by an active transport mechanism, which keeps the intracellular level of hydrophobic compounds below a cell-killing threshold. Human MDR1 variants with mutations affecting a conserved glycine residue within the ABC signature of either or both ABC units (G534D, G534V, G1179D and G534D/G1179D) were expressed and characterized in Spodoptera frugiperda (Sf9) cell membranes. These mutations caused a loss of measurable ATPase activity but still allowed ATP binding and the formation of a transition-state intermediate (nucleotide trapping). In contrast with the wild-type protein, in which substrate drugs accelerate nucleotide trapping, in the ABC signature mutants nucleotide trapping was inhibited by MDR1-substrate drugs, suggesting a miscommunication between the drug-binding site(s) and the catalytic domains. Equivalent mutations of the two catalytic sites resulted in a similar effect, indicating the functional equivalence of the two sites. On the basis of these results and recent structural information on an ABC-ABC dimer [Hopfner, Karcher, Shin, Craig, Arthur, Carney and Tainer (2000) Cell 10...Continue Reading

References

Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Sep 1, 1991·Journal of Cellular Physiology·E GeorgesV Ling
Nov 10, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Aug 18, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Dec 27, 1995·FEBS Letters·A E SeniorI L Urbatsch
May 1, 1997·Archives of Biochemistry and Biophysics·B SankaranA E Senior
Jun 3, 1997·Biochemistry·B SankaranA E Senior
Dec 3, 1999·Biochimica Et Biophysica Acta·I KleinA Váradi
Oct 12, 2000·Biochemical and Biophysical Research Communications·G SzakácsA Váradi

❮ Previous
Next ❯

Citations

Dec 26, 2006·Pflügers Archiv : European journal of physiology·Eva Bakos, László Homolya
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cedric OrelleAmy L Davidson
Jul 3, 2009·The Journal of Biological Chemistry·Sonia PaytubiChristopher G Proud
Aug 10, 2002·The EMBO Journal·Michinori MatsuoFrances M Ashcroft
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jul 5, 2001·Biochemical and Biophysical Research Communications·C OzvegyB Sarkadi
Jul 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Erin E Fetsch, Amy L Davidson
Feb 9, 2012·Journal of Amino Acids·Rajendra PrasadManpreet Kaur Rawal
Aug 28, 2010·Protein Science : a Publication of the Protein Society·Libusha KellyAndrej Sali
Jul 9, 2004·Biochemical and Biophysical Research Communications·Cheol-Hee ChoiSang-Hyun Kim
May 1, 2007·Environmental Toxicology and Pharmacology·Joon-Ho KimCheol-Hee Choi
Dec 15, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Suresh V AmbudkarZuben E Sauna
Aug 10, 2005·Mutation Research·Lynnette R Ferguson, Silvio De Flora
Sep 12, 2015·BioMed Research International·Eva Y G De VilderOlivier M Vanakker
Sep 25, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Agnes KarasikFlóra Szeri
Nov 8, 2002·The Journal of Biological Chemistry·Tip W LooDavid M Clarke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.